TGF-β1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3ε mAb- and CD28 mAb-activated splenocytes and thymocytes

被引:22
作者
McKarns, SC [1 ]
Kaminski, NE [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
来源
IMMUNOPHARMACOLOGY | 2000年 / 48卷 / 02期
关键词
TGF-beta(1); splenocyte; thymocyte; T-cell; interleukin-2; proliferation; CD3; CD28;
D O I
10.1016/S0162-3109(00)00183-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transforming growth Factor-beta, (TGF-beta(1)) is a critical bifunctional regulator of inflammatory responses. Evidence strongly suggests that these regulatory consequences are, at least in part, a result of profound pleiotropic effects on T lymphocyte effector function. The mechanisms underlying the contradictory biological effects of TGF-beta(1) remain ambiguous. The objective of the present studies was to test the hypothesis that the concentration of TGF-beta(1) and the temporal relationship between activation of the T cell receptor (TCR) and the TGF-beta receptor regulate the effect of TGF-beta(1) on T lymphocyte activation and proliferation. Toward this end, we have quantified the concentration- and time-dependent effect of TGF-beta(1) on interleukin-2 (IL-2) protein secretion as an index of T lymphocyte activation and [H-3]-thymidine incorporation as an index of cell proliferation in primary splenocytes and thymocytes. Our results suggest that TCF-beta(1) stimulates IL-2 production at low concentrations (0.1-1 pg/ml) and conversely inhibits IL-2 production at high concentrations (1-10 ng/ml) in CD3 epsilon monoclonal antibody (mAb) +/- CD28 mAb-activated splenocytes. Additionally, concentrations of TGF-beta(1) that simulate IL-2 production in CD3 epsilon mAb + CD28 mAb-activated splenocytes concominantly inhibit splenocyte proliferation under similar conditions. Furthermore, we provide evidence suggesting that the effects of TGF-beta(1) on T lymphocytes are dependent upon the temporal relationship between activation of the TCR and the TGF-beta receptor. A time-dependent loss of a stimulatory effect and a concomitant gain of an inhibitory response by TGF-beta(1) on IL-2 production in response to CD3 epsilon and CD28 mAbs is observed when TGF-beta(1) is added following T lymphocyte activation. In summary, these data unequivocally demonstrate that the orchestration of paradoxical effects of TGF-beta(1) on T-lymphocyte function is dependent upon the concentration of TGF-beta(1) and the temporal relationship between activation of signaling through the TCR and the TGF-beta receptor. Future mechanistic studies addressing the putative role that these factors play in modulating the effects of TGF-beta(1).
引用
收藏
页码:101 / 115
页数:15
相关论文
共 40 条
[1]  
ADAMS DH, 1991, J IMMUNOL, V147, P609
[2]   Transforming growth factor-beta negatively modulates T-cell responses in sepsis [J].
Ahmad, S ;
Choudhry, MA ;
Shankar, R ;
Sayeed, MM .
FEBS LETTERS, 1997, 402 (2-3) :213-218
[3]   The functional role of B7 molecules on the induction of thymocyte activation and apoptosis [J].
Aoki, N ;
Inobe, M ;
Murakami, M ;
Abe, R ;
Iizuka, H .
MICROBIOLOGY AND IMMUNOLOGY, 1998, 42 (08) :555-565
[4]   Placental macrophage contact potentiates the complete replicative cycle of human cytomegalovirus in syncytiotrophoblast cells:: Role of interleukin-8 and transforming growth factor-β1 [J].
Bácsi, A ;
Aranyosi, J ;
Beck, Z ;
Ebbesen, P ;
Andirkó, I ;
Szabó, J ;
Lampé, L ;
Kiss, J ;
Gergely, L ;
Tóth, FD .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (10) :1153-1160
[5]   CD28 AND APOPTOSIS [J].
BOISE, LH ;
NOEL, PJ ;
THOMPSON, CB .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (05) :620-625
[6]   TRANSFORMING GROWTH-FACTOR-BETA AND CYCLOSPORINE-A INHIBIT THE INDUCIBLE ACTIVITY OF THE INTERLEUKIN-2 GENE IN T-CELLS THROUGH A NONCANONICAL OCTAMER-BINDING SITE [J].
BRABLETZ, T ;
PFEUFFER, I ;
SCHORR, E ;
SIEBELT, F ;
WIRTH, T ;
SERFLING, E .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (02) :1155-1162
[7]  
Cerwenka A, 1996, J IMMUNOL, V156, P459
[8]  
CERWENKA A, 1994, J IMMUNOL, V153, P4367
[9]   Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model [J].
Chernajovsky, Y ;
Adams, G ;
Triantaphyllopoulos, K ;
Ledda, MF ;
Podhajcer, OL .
GENE THERAPY, 1997, 4 (06) :553-559
[10]  
CHRIST M, 1994, J IMMUNOL, V153, P1936